CGTX
NASDAQ · Pharmaceuticals
Cognition Therapeutics Inc
$0.70
-0.04 (-5.57%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+4,334.3% upside
Low Target
$22.83
Average Target
$30.96
High Target
$36.58
Current Price
$0.70
Current
$0.70
$0.70
Target
$30.96
$30.96
$22.83
$30.96 avg
$36.58
Scenario Analysis
Bear Case
$22.83
3,169.8%
Low target
Base Case
$30.96
+4,334.3%
Avg target
Bull Case
$36.58
+5,139.2%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$1.83
-61.7% from high
52-Week Low
$0.55
+26.9% from low
Target vs 52W High
$30.96
+1,596.4% vs high
Next Earnings Report
Nov 18, 2026
10d
until earnings
EPS Est: $-0.07
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals